SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,163 | -25.4% | 6,387 | 0.0% | 0.00% | – |
| Q2 2023 | $29,700 | -0.1% | 6,387 | -0.7% | 0.00% | – |
| Q1 2023 | $29,720 | -42.8% | 6,433 | 0.0% | 0.00% | – |
| Q4 2022 | $51,979 | +205.8% | 6,433 | +106.3% | 0.00% | – |
| Q3 2022 | $17,000 | -98.8% | 3,118 | -98.9% | 0.00% | -100.0% |
| Q2 2022 | $1,447,000 | +10235.7% | 277,760 | +30289.5% | 0.00% | – |
| Q4 2021 | $14,000 | -64.1% | 914 | -55.9% | 0.00% | – |
| Q3 2021 | $39,000 | 0.0% | 2,074 | -0.7% | 0.00% | – |
| Q2 2021 | $39,000 | -99.5% | 2,089 | -99.4% | 0.00% | -100.0% |
| Q1 2021 | $7,483,000 | +161.6% | 328,774 | +149.5% | 0.02% | +150.0% |
| Q4 2020 | $2,861,000 | +9765.5% | 131,797 | +3440.1% | 0.01% | – |
| Q2 2020 | $29,000 | – | 3,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |